COVID-19
T Cell Receptor Sequencing Identifies Prior SARS-CoV-2 Infection and Correlates With Neutralizing Antibodies and Disease Severity
Researchers from the University of Washington have made a groundbreaking discovery in the study of COVID-19, revealing that T cell receptor sequencing can identify past SARS-CoV-2 infection and correlate with neutralizing antibodies and disease severity. The study, published in JCI Insight, used small-volume blood samples from 302 individuals recovered from